05 Dec 2024
08:02 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES VALIDE L’INDUSTRIALISATION DE NFL-101 POUR LE SEVRAGE TABAGIQUE
|
20103010 Biotechnology |
Legal |
05 Dec 2024
08:02 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES VALIDATES THE INDUSTRIALIZATION OF NFL-101 FOR SMOKING CESSATION
|
20103010 Biotechnology |
Legal |
18 Nov 2024
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : LE MÉCANISME D’ACTION NOUVEAU ET DISRUPTIF DE NFL-101 POUR LE SEVRAGE TABAGIQUE PRÉSENTÉ AU CONGRÈS ANNUEL DE LA SOCIÉTÉ FRANCOPHONE DE TABACOLOGIE
|
20103010 Biotechnology |
Legal |
18 Oct 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: LEADERSHIP TEAM PREPARING THE NEXT STAGES IN ITS DEVELOPMENT
|
20103010 Biotechnology |
Legal |
18 Oct 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : L’ÉQUIPE DIRIGEANTE PRÉPARE LES PROCHAINES ÉTAPES DU DÉVELOPPEMENT
|
20103010 Biotechnology |
Legal |
08 Oct 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: EFFICACY VALIDATED THROUGH UPDATED ANALYSES FROM CESTO II FOR SMOKING CESSATION. SIGNIFICANT REDUCTION IN CRAVING. STRONG COMMERCIAL POTENTIAL CONFIRMED.
|
20103010 Biotechnology |
Legal |
08 Oct 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : VALIDATION DE L’EFFICACITÉ PAR DES ANALYSES ACTUALISÉES DE CESTO II EN SEVRAGE TABAGIQUE. RÉDUCTION SIGNIFICATIVE DU CRAVING. FORT POTENTIEL COMMERCIAL CONFIRMÉ.
|
20103010 Biotechnology |
Legal |
27 Sep 2024
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
|
20103010 Biotechnology |
General meeting / Board Meeting |
27 Sep 2024
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS DU 1er SEMESTRE 2024
|
20103010 Biotechnology |
General meeting / Board Meeting |
09 Sep 2024
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: PARTICIPATION CALENDAR PHARMA EVENTS AND INSTITUTIONAL INVESTORS
|
20103010 Biotechnology |
Legal |
09 Sep 2024
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : AGENDA DE PARTICIPATION ÉVÉNEMENTS PHARMA ET INVESTISSEURS INSTITUTIONNELS
|
20103010 Biotechnology |
Legal |
15 Jul 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: CESTO II STUDY RESULTS
|
20103010 Biotechnology |
Other subject |
15 Jul 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : RÉSULTATS DE L’ÉTUDE CESTO II
|
20103010 Biotechnology |
Other subject |
11 Jul 2024
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ DU 1er SEMESTRE 2024
|
20103010 Biotechnology |
Other subject |
17 Jun 2024
11:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : publication scientifique de l\'étude sur le mécanisme d\'action de NFL-101 menée par le CEA dans ACS Chemical Neuroscience
|
20103010 Biotechnology |
Legal |
17 Jun 2024
11:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: Scientific publication of the study on the mechanism of action of NFL-101 conducted by the CEA in ACS Chemical Neuroscience
|
20103010 Biotechnology |
Legal |
31 May 2024
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 30 MAI 2024
|
20103010 Biotechnology |
Other subject |
31 May 2024
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: RESULTS OF THE COMBINED GENERAL MEETING OF MAY 30, 2024
|
20103010 Biotechnology |
Other subject |
29 May 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : Presentation of the study results conducted with the CEA at the Albatross congress
|
20103010 Biotechnology |
Other subject |
29 May 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : présentation des résultats de l\'étude menée avec le CEA, au congrès de l\'Albatros
|
20103010 Biotechnology |
Other subject |
21 May 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: POSITIVE FDA RESPONSE FOLLOWING THE PRE-IND APPLICATION FOR NFL-301 FOR REDUCING ALCOHOL CONSUMPTION
|
20103010 Biotechnology |
Other subject |
21 May 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : RETOUR POSITIF DE LA FDA SUR LA DEMANDE DE PRE-IND POUR NFL-301 DÉDIÉ À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL
|
20103010 Biotechnology |
Other subject |
15 May 2024
17:45 CEST |
NFL BIOSCIENCES |
NFL Biosciences : Assemblée générale mixte du 30 mai 2024
|
20103010 Biotechnology |
Income |
18 Apr 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences further strengthens its operational team with the arrival of a Head of Development and Manufacturing
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences renforce son équipe opérationnelle avec l’arrivée d’une Responsable du développement et de la fabrication
|
20103010 Biotechnology |
Other subject |
12 Apr 2024
07:45 CEST |
NFL BIOSCIENCES S.A. |
Succès de l’opération de NFL Biosciences avec plus de 3 millions d’euros levés par voie d’augmentation de capital
|
20103010 Biotechnology |
Other subject |
12 Apr 2024
07:45 CEST |
NFL BIOSCIENCES S.A. |
Successful capital increase for NFL Biosciences with over €3 million raised
|
20103010 Biotechnology |
Other subject |
11 Apr 2024
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences lance une levée de fonds d’environ 3 millions d’euros par voie d’augmentations de capital
|
20103010 Biotechnology |
Mergers, Acquiqitions, Transferts |
11 Apr 2024
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences launches a fundraising round for 3 million euros through a capital increase
|
20103010 Biotechnology |
Mergers, Acquiqitions, Transferts |
02 Apr 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES VALORISE SES RÉSULTATS D’ÉTUDES AUPRÈS DE LA COMMUNAUTÉ SCIENTIFIQUE ET PHARMACEUTIQUE
|
20103010 Biotechnology |
Legal |
02 Apr 2024
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES SHOWCASES THE RESULTS OF ITS STUDIES TO THE SCIENTIFIC AND PHARMACEUTICAL COMMUNITIES
|
20103010 Biotechnology |
Legal |
29 Mar 2024
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
|
20103010 Biotechnology |
Other subject |
29 Mar 2024
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS ANNUELS 2023
|
20103010 Biotechnology |
Other subject |
11 Mar 2024
08:55 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS
|
20103010 Biotechnology |
Other subject |
11 Mar 2024
08:55 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP
|
20103010 Biotechnology |
Other subject |
13 Feb 2024
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES PRÉSENTERA LES RÉSULTATS DE L’ÉTUDE PRECESTO LORS DU CONGRÈS DE LA SRNT, LA SOCIÉTÉ SCIENTIFIQUE DE RÉFÉRENCE AU NIVEAU MONDIAL DANS LA LUTTE CONTRE LE TABAGISME
|
20103010 Biotechnology |
Other subject |
13 Feb 2024
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES WILL PRESENT THE RESULTS OF THE PRECESTO CLINICAL STUDY AT THE SRNT CONFERENCE, THE WORLD\'S LEADING SCIENTIFIC SOCIETY IN THE FIELD OF NICOTINE AND TOBACCO RESEARCH
|
20103010 Biotechnology |
Other subject |
30 Jan 2024
08:00 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: SUCCESS OF THE STUDY WITH THE CEA
|
20103010 Biotechnology |
Other subject |
30 Jan 2024
08:00 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : SUCCÈS DE L’ÉTUDE AVEC LE CEA
|
20103010 Biotechnology |
Other subject |
12 Jan 2024
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES CONFIRME SON ÉLIGIBILITÉ AU DISPOSITIF PEA-PME
|
20103010 Biotechnology |
Legal |
09 Jan 2024
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: FINANCIAL CALENDAR FOR 2024
|
20103010 Biotechnology |
Legal |
09 Jan 2024
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : AGENDA DE COMMUNICATION FINANCIÈRE 2024
|
20103010 Biotechnology |
Legal |
08 Jan 2024
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ 2ème SEMESTRE 2023
|
20103010 Biotechnology |
Other subject |
19 Dec 2023
08:00 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : DÉPÔT D’UNE DEMANDE DE PRE-IND AUPRÈS DE LA FDA AUX ÉTATS-UNIS POUR NFL- 301 DÉDIÉ À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL
|
20103010 Biotechnology |
Other subject |
19 Dec 2023
08:00 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: PRE-IND APPLICATION FILED WITH THE FDA IN THE UNITED STATES FOR NFL-301, INDICATED FOR REDUCING ALCOHOL CONSUMPTION
|
20103010 Biotechnology |
Other subject |
05 Oct 2023
19:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: 2023 FIRST-HALF BUSINESS AND EARNINGS UPDATE
|
20103010 Biotechnology |
Other subject |
05 Oct 2023
19:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS DU 1ER SEMESTRE 2023
|
20103010 Biotechnology |
Other subject |
25 Sep 2023
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : RESULTATS PROMETTEURS DE L'ETUDE CLINIQUE PRECESTO REVELANT UN EFFET PROLONGE DE NFL-101 ET MODIFICATION DE LA STRATEGIE DE COMMUNICATION DES RESULTATS DE L’ETUDE CESTO II
|
20103010 Biotechnology |
Other subject |
25 Sep 2023
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: PROMISING RESULTS OF THE PRECESTO CLINICAL TRIAL REVEALING A PROLONGED EFFECT FOR NFL-101 AND MODIFICATION OF THE STRATEGY FOR COMMUNICATING THE CESTO II STUDY RESULTS
|
20103010 Biotechnology |
Other subject |
18 Jul 2023
08:00 CEST |
NFL BIOSCIENCES S.A. |
Nfl Biosciences: Patent Application Filed in the United States for Reducing Alcohol Consumption With Nfl-301 & Preparation of a Pre-Ind Application Submission With the Fda
|
20103010 Biotechnology |
- |